Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orally bioavailable CB<sub>2</sub> receptor agonists attenuate neuroinflammation and stabilize the blood-brain barrier.

Research square·2026
Same author

Light-controlled disruption of cancer cell dormancy via photoswitchable stress hormone receptor degraders.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Foamy microglia link oxylipins to disease progression in multiple sclerosis.

Nature neuroscience·2026
Same author

Activating p53<sup>Y220C</sup> with a mutant-specific small molecule.

Nature communications·2026
Same author

Celebrating the 150th Anniversary of the American Chemical Society.

Journal of the American Chemical Society·2026
Same author

Single-position ligand modifications tune CB<sub>2</sub>R activity by targeting the toggle switch.

Chemical science·2026

Related Experiment Video

Updated: Dec 30, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.1K

Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.

Matthias V Westphal1, Roman C Sarott1, Elisabeth A Zirwes2

  • 1Laboratorium für Organische Chemie, Eidgenössische Technische Hochschule Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland.

Chemistry (Weinheim an Der Bergstrasse, Germany)
|January 22, 2020
PubMed
Summary
This summary is machine-generated.

Researchers developed novel, highly selective cannabinoid receptor 2 (CB2R) agonists. These new compounds are valuable tools for studying the endocannabinoid system and its role in various diseases.

Keywords:
CB2Rcannabinoid receptor 2chemical probeelectrophilic ligandsendocannabinoid systemfluorescent probe

More Related Videos

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
16:16

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Published on: September 13, 2013

15.7K
Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.5K

Related Experiment Videos

Last Updated: Dec 30, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.1K
Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
16:16

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Published on: September 13, 2013

15.7K
Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.5K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Neuroscience

Background:

  • The endocannabinoid (eCB) system plays a role in numerous human diseases.
  • Cannabinoid receptor 2 (CB2R) is a key component of the eCB system, but its functions are not fully understood due to limited research tools.
  • Understanding CB2R signaling is crucial for developing treatments for CNS and autoimmune disorders.

Purpose of the Study:

  • To design and synthesize novel CB2R-selective cannabinoid ligands.
  • To characterize the pharmacological properties of these new compounds in vitro.
  • To develop improved chemical and biological tools for studying the CB2R.

Main Methods:

  • Design and synthesis of chimeric cannabinoid ligands combining structural elements of HU-308 and AM841.
  • In vitro pharmacological characterization, including binding assays and functional studies.
  • Convenient preparation of substituted resorcinols, common in cannabinoid structures.

Main Results:

  • Successful synthesis of potent CB2R agonists with high selectivity over CB1R.
  • Demonstrated utility of the synthetic cannabinoids through the creation of a highly selective, high-affinity fluorescent probe for CB2R.
  • Chimeric ligands exhibit promising pharmacological profiles for CB2R research.

Conclusions:

  • The developed chimeric cannabinoids represent valuable, selective tools for investigating CB2R.
  • These novel compounds and the fluorescent probe advance research into the endocannabinoid system's role in disease.
  • The synthetic strategies provide efficient access to important cannabinoid scaffolds.